Skip to content
Research Article Open access CC BY 4.0

Enhancement of Solubility and Dissolution Rate of BCS Class-II Fluvoxamine Tablets using Solvent Evaporation Solid Dispersion Technique

Martha Srinivas, Anoop Singh

Journal of Pharmaceutical Research International · pp. 44–53 · Published 12 Jun 2021

10.9734/jpri/2021/v33i31B31689

Abstract

Aim: This research work was aimed to formulate Enhancing the solubility of Poorly soluble drug i.e. Fluvoxamine tablets by the solvent evaporation method, Fluvoxamine medicament is a selective serotonin reuptake inhibitor (SSRI) antidepressant agent. Purpose: The BCS class II drug Fluvoxamine consist low aqueous solubility and low oral bioavailability, for this reason to improve the biological performance of Fluvoxamine drug by solid dispersion mechanism. Methodolgy: The drug Fluvoxamine was formulated by using solvent evaporation technique, solid dispersions of Fluvoxamine were prepared with different carriers in different ratios of PEG 6000 & Mannitol (1:1, 1:2 and 1:3). Results: Results of prepared solid dispersions of Fluvoxamine by solid dispersion method Finally by comparing all the formulations, formulation (SF3) containing Fluvoxamine and PEG 6000 (1:3) shows better results. Conclusion: Here we concluded that the poorly soluble drug solubility improving by solvent evaporation solid dispersion mechanism, and also developed six Fluvovamine formulations (FDF1-FDF6) during this FDF4 shows maximum (98.9±0.8%) drug release at the end of time.

Fluvoxamine antidepressant PEG 6000 mannitol solvent evaporation direct compression method

Cited by 8

Formulation and Characterization of Carvedilol In situ Gels for Oral Delivery- In vitro and In vivo Pharmacokinetic Studies

S.K. Madhavi Harika, M. Sudhakar, V.V. Basava Rao · Analytical Chemistry Letters · 2022

Development of sustained release oral disintegrating tablet of fluvoxamine maleate

Esraa A. Shetaa, Mona F. Arafa, Sally E. Abu-Risha · Pharmaceutical Development and Technology · 2025

Advanced oxidation processes for degradation of pharmaceuticals used during COVID-19 pandemic

Irwing Ramirez, Ezrah Mariam, Ajay Kumar · Sustainable Technologies for Remediation of Emerging Pollutants from Aqueous Environment · 2024

Strategies to Enhance the Bioavailability of Hydrophilic Drugs Using Natural Bioenhancers

Mohan V. Kodli, Prerana K. Raikar, Pooja Kulkarni · Biomedical Materials & Devices · 2025

Formulation and characterization of nimodipine in situ gels for oral delivery

S. K. Madhavi Harika, M. Sudhakar, V. V. Basava Rao · International journal of health sciences · 2022

SOLID DISPERSION TABLETS IN IMPROVING ORAL BIOAVAILABILITY OF POORLY SOLUBLE DRUGS

PRASENJIT SARKAR, SAUMYAJYOTI DAS, SUTAPA BISWAS MAJEE · International Journal of Current Pharmaceutical Research · 2022

Antidepressant pharmaceuticals in aquatic systems, individual-level ecotoxicological effects: growth, survival and behavior

Karolina Słoczyńska, Justyna Orzeł, Aleksandra Murzyn · Aquatic Toxicology · 2023

Formulation and Optimization of Dolutegravir Fast Dissolving Tablets Using Various Solubility Enhancement Methods

Martha Srinivas, Anoop Singh · International Journal of Life Science and Pharma Research · 2021

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

8

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.